PharmExec Blog
Follow Us
RSS
Bookstore
Technology News- BioPharm News
- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
- Clinical Trials News
- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Tag Archives: Advertising
Google Unveils New Pharma Ads
Image via CrunchBase
Google just showed off mockups of its fancy new pharma ads at FDA’s social media hearing, on November 12. A few months back, the big G mentioned that it was working on ads to appease both pharmaceutical marketers and FDA, but this is the first time most people got to lay eyes on [...]
Posted in Strategy Also tagged Food and Drug Administration, Google, Health care, Search, Search Engines, Uniform Resource Locator, Yahoo 1 Comment
Pfizer Quietly Updates Company Logo
A few weeks back, about the time Pfizer started swapping out Wyeth signs for Pfizer branding, I was tipped off that the age-old Pfizer logo had been modified from the horizontal blue oval to an offset design.
Additionally, the company did tiny modifications on each letter, dropping the serif from the “P,” making the “F” less [...]
Feds Chase Down Faulty Skincare Promos
FDA’s Division of Drug Marketing Communications, this week, posted a slew of warning and untitled letters to pharma firms for misleading skincare advertisements. Johnson & Johnson, Galderma, and Allergan each received a letter documenting complaints ranging from false advertising to unsubstantial efficacy claims.
J&J received a violation letter in response to a journal ad for its [...]
Posted in FDA, Marketing Also tagged Allergan, Clinical trial, Johnson & Johnson, U.S. Food and Drug Administration 1 Comment
Building a Better Brief Summary
Image via Wikipedia
FDA wanted to find out what people really think of the risk information printed on the back of pharmaceutical advertising. Surprise, people tend to absorb far less information from the giant blocks of text printed in drab language.
DDMAC social science analyst Amy O’Donoghue explained FDA’s recent study results to an audience of marketers [...]
New FDA Campaign Targets Detailing, Trade Shows